Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Horizon 2020

Founders Ana Querido Rita

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 213
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 188
Rounds per year 4.02
Lead investments 68
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Exits 9
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Medical Device
  • Medical
Summary

We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Health Care. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline DNA Script, Sol Voltaics, Infarm Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The common things for fund are deals in the range of 1 - 5 millions dollars. The increased amount of exits for fund were in 2019. The fund is generally included in 25-48 deals every year. Comparing to the other companies, this Horizon 2020 performs on 25 percentage points less the average number of lead investments. The important activity for fund was in 2019. Speaking about the real fund results, this Corporate Investor is 41 percentage points more often commits exit comparing to other organizations. The typical startup value when the investment from Horizon 2020 is 1-5 millions dollars.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Horizon 2020, startups are often financed by Venture Kick, Tekes, Enterprise Ireland. The meaningful sponsors for the fund in investment in the same round are EASME - EU Executive Agency for SMEs, Tekes, Maki.vc. In the next rounds fund is usually obtained by European Bank for Reconstruction and Development, EIT Health, UCLB.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Horizon 2020:
Typical Co-investors
Horizon 2020 is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Horizon 2020:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MUVON Therapeutics

Biotechnology
Health Care
Life Science
31 May 2021 Zürich, Zurich, Switzerland

Qblox

Information Technology
Quantum Computing
Software
$5M11 Jan 2021 South Holland

Satelligence

Analytics
Information Technology
Natural Resources
Sensor
$2M25 Nov 2020 Utrecht, Utrecht, The Netherlands

Ovon Home

Energy
Energy Efficiency
Hardware
Information Technology
Internet of Things
Software
$73K01 Oct 2020 Manchester, England, United Kingdom

BotsAndUs

Artificial Intelligence
Autonomous Vehicles
Hospitality
Machine Learning
Retail Technology
Robotics
$2M06 Jul 2020 London, England, United Kingdom

CyanoGuard AG

Biotechnology
Chemical
Health Care
Quality Assurance
Water
$3M14 Apr 2020 Zurich, Switzerland

Coffee Cloud

Analytics
Big Data
Information Technology
Internet of Things
Machine Learning
SaaS
$890K01 Jan 2020 London, England, United Kingdom

ultimate.ai

Artificial Intelligence
CRM
Customer Service
Enterprise Software
SaaS
Virtual Assistant
$3M04 Nov 2019 Berlin, Berlin, Germany

Sorek Medical Systems

3D Printing
Hospital
Medical
Medical Device
$2M01 Oct 2019 Israel, North District, Israel

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Horizon 2020?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 213
Average round size 2M
Rounds per year 4.02
Peak activity year 2019
Lead investments 68
Follow on index 0.11
Exits 9
Group Appearance index 0.19

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

MUVON Therapeutics

Biotechnology
Health Care
Life Science
31 May 2021 Zürich, Zurich, Switzerland

Qblox

Information Technology
Quantum Computing
Software
$5M11 Jan 2021 South Holland

Satelligence

Analytics
Information Technology
Natural Resources
Sensor
$2M25 Nov 2020 Utrecht, Utrecht, The Netherlands

Ovon Home

Energy
Energy Efficiency
Hardware
Information Technology
Internet of Things
Software
$73K01 Oct 2020 Manchester, England, United Kingdom

BotsAndUs

Artificial Intelligence
Autonomous Vehicles
Hospitality
Machine Learning
Retail Technology
Robotics
$2M06 Jul 2020 London, England, United Kingdom

CyanoGuard AG

Biotechnology
Chemical
Health Care
Quality Assurance
Water
$3M14 Apr 2020 Zurich, Switzerland

Coffee Cloud

Analytics
Big Data
Information Technology
Internet of Things
Machine Learning
SaaS
$890K01 Jan 2020 London, England, United Kingdom

ultimate.ai

Artificial Intelligence
CRM
Customer Service
Enterprise Software
SaaS
Virtual Assistant
$3M04 Nov 2019 Berlin, Berlin, Germany

Sorek Medical Systems

3D Printing
Hospital
Medical
Medical Device
$2M01 Oct 2019 Israel, North District, Israel
Crunchbase icon

Content report

The following text will be sent to our editors: